Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 4Phase 3 2Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 8Letrozole 3Pharmaceutical Preparations 2semaglutide 1salicylsalicylic acid 1mirabegron 1drospirenone and ethinyl estradiol combination 1Vitamins 1Thioctic Acid 1Progesterone 1Itraconazole 1Inositol 1Hydroquinones 1Gonadotropin-Releasing Hormone 1Flutamide 1Flour 1Fish Oils 1Docosahexaenoic Acids 1Clomiphene 1Ascorbic Acid 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Polycystic Ovary Syndrome × drospirenone and ethinyl estradiol combination × Clear all
NCT01603745 2012-05-22

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Catholic University of the Sacred Heart

Phase 1 Unknown
10 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡